|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02185 BIOHEART-B
Nominal 
1.815 -0.010 (-0.548%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 14,377 | -31.085% | 44,932 | 0 | 0 | 0 |
| Cost of Sales | (7,655) | -31.450% | (26,916) | -- | -- | -- |
| Gross Profit | 6,722 | -30.665% | 18,016 | -- | -- | -- |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | (1,467) | (986) | (1,633) | (1,430) | |
| Profit / (Loss) before Taxation | (33,375) | 21.718% | (96,003) | (93,324) | (188,820) | (230,868) | |
| Taxation | 141 | -79.446% | 27,569 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 574 | -- | (1,619) | 5,380 | 12,927 | 26,632 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (32,660) | 20.016% | (70,053) | (87,944) | (175,893) | (204,236) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 4,398 | -25.647% | 6,731 | (1,042) | (3,422) | (3,051) |
| Depreciation & Amortisation | 10,271 | 32.154% | 18,178 | 8,174 | 21,355 | 20,857 |
| Directors' Emoluments | -- | -- | -- | 3,575 | 39,255 | 104,729 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -13.000 | 18.182% | -29.000 | -36.000 | -72.000 | -84.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.278) | (0.491) | (0.201) | (0.577) |
| NBV per share ($) | 1.652 | -- | 1.786 | 2.708 | 3.068 | 3.621 |
| Remarks: | Real time quote last updated: 04/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -32,660 |
| %Change | 20.016% |
| EPS / (LPS) | RMB -0.130 |
| NBV Per Share (¥) | RMB 1.652 |